Monokines have been increasingly recognized as communication signals that interact with both immune and non-immune cells during inflammation. Specifically, interleukin-lalpha (IL-lalpha), interleukin-lbeta (IL-lbeta) and tumor necrosis factoralpha (TNF-alpha) possess potent effector activities on various cell types. We present novel data demonstrating that human endothelial ceils are a major source of a neutrophil chemotactic factor (NCF) synthesized upon stimulation with either ILlalpha, IL-lbeta, or TNF-alpha; but not with interleukin-6 (IL-6). Northern blot analysis demonstrated that 20 ng/ml of either IL-1 or TNF-alpha could induce endothelial ceils to express significant levels of NCF mRNA, while IL-6 was not active in this system. These data demonstrate that monokines play an important role in mediating acute inflammation via induction of an endothelial cell-derived NCF.
neutrophils in a localized area of tissue injury, yet this process does not account for the selective influx of neutrophils into an area of local inflammation.
In this paper, we present novel data demonstrating that monokine-activated endothelial cells may further contribute to acute inflammation by the production of a specific neutrophil chemotactic factor (NCF). Either IL-1 alpha, IL-1 beta, or TNFalpha-treated endothelial cells induced a time-and dose-dependent increase in NCF mRNA expression and the production of chemotactic activity. The induction of NCF mRNA and the secretion of biologically-active protein possessed a degree of cytokine selectivity, as interleukin-6-treated human endothelial cells was not effective in this
system. These studies demonstrate that either IL-1 or TNF can induce NCF gene expression by endothelial cells and this factor may play a major role in the early influx of neutrophils from the circulation.
Materials and Methods
Endothelial Cell Populations: Human endothelial cells were isolated from umbilical veins according to previously published procedures (8) . The recovered endothelial cells were cultured in medium 199 supplemented with 100 ng/ml endothelial cell growth supplement, 25% fetal bovine serum, and 100 ng/ml bovine lung heparin. All cells in these studies were used prior to their fifth passage in culture. Twenty-four hours before stimulation, the endothelial cells were washed and new media, minus growth factors, were added. Reagents: Human recombinant IL-lalpha and IL-lbeta with specific activities of 20 U/ng and 30 U/ng, respectively, were the generous gifts of the Upjohn Company. Human recombinant TNF (20 U/ng, specific activity) was a gift of the Cetus Corporation. Human recombinant IL-6 (20 U/ul) was purchased from Genzyme Inc. Northern Blot Analysis:
Total endothelial cell RNA was extracted using a modification of the methods of Jonas et al. (9) . and Chirgwin et al. (10) . The adherent endothelial cells were solubilized in a solution of 25 mM Tris, pH 8.0 containing 4.2 M guanidine isothiocyanate, 0.5% Sarkosyl and 0.1 M beta-mercaptoethanol. After homogenization, an equal volume of 100 mM Tris, pH 8.0 containing 1.0% SDS and 10 mM EDTA was added and the RNA extracted with chloroform-phenol. The alcohol precipitated RNA was separated by formaldehyde/l% agarose gels and transblqt//ed to nitrocellulose. The baked blots were prehybridized and then hybridized with a J~P -5'-end labeled 30 mer oligonucleotide probe. The probe was complementary to nucleotides 262-291 of a published cDNA sequence for human monocyte-derived NCF (11) . The sequence of the probe was 5'-GTT-GGC-GCA-GTG-TGG-TCC-ACT-CTC-ATI~-CAC-3 '. Blots were stringency washed and autoradiographs were quantitated by laser densitometry. Equivalent amounts of total RNA load per gel lane were assessed by monitoring 28 and 18S rRNA. Neutrophil Chemotactic Factor Assay:
Human neutrophils were prepared from peripheral blood by Ficoll-Hypaque density gradient centrifugation, followed by sedimentation in 5% Dextran/0.9% saline (Sigma Chemical Co., St. Louis, MO). Neutrophils were isolated from erythrocytes by hypotonic lysis then resuspended in Hanks balanced~salt solution (HBSS) with calcium/magnesium (Gibco, Grand Island, NY) at 2 x 10 u cells/ml with greater than 95% viability by trypan blue exclusion. Chemotaxis was performed using Oe method of Harvath et al (12) . Briefly, 20 ul of diluted supernatant specimen, 10 -I M formyl methionylleucylphenylalanine (FMLP, Sigma Chemical Co., St. Louis, MO) or HBSS alone were placed in duplicate bottom wells or a 48-well microchemotaxis chamber (Neuro probe, Cabin John, MD). A 3 micron pore-size polycarbonate filter (polyvinylpyrolidone-free, Nucleopore Corp.) was placed in the assembly and 50 ul of neutrophil suspension placed in each of the top wells. After incubating at 37°C in humidified 95% air/5% ~O~ for 0.5 hrs, the filters were removed, fixed in methanol, and stained with Diff-Quil~ (American Scientific Products, McGaw Park, IL). Neutrophils that had migrated through to the bottom of the filter were counted in 10 high power fields. Chemotactic activity was assessed as percent of the FMLP positive control. Figure 2 . Production of neutrophil chemotactic activity by either IL-1 alpha, IL-1 beta, or TNF-alpha treated human endothelial cells. The endothelial cells were exposed to each cytokine (200 Units/ml) for 16 hours and the supernatant was assessed for neutrophil chemotactic activity. Both IL-1 and TNF-alpha effectively induced the synthesis of de novo chemotactic activity, while IL-6 was ineffective in this system.
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Figure3.
Time-dependent production of neutrophil chemotactic activity by monokine treated endothelial cells. Both IL-1 alpha and IL-1 beta (200 Units/ml) treated endothelial cells demonstrated a time-dependent increase in the production of NCF. Although the secretion of endothelial cell NCF was initially low (0-4 hours), the production significantly increased at the 8 and 24 hour time points. TNF-alpha treated human endothelial cells exhibited a similar kinetic pattern of NCF expression. In addition to influencing neutrophil function via the induction of specific adherence proteins, we now demonstrate that either IL-lalpha, IL-lbeta, or TNF can stimulate endothelial cells to produce a potent neutrophil chemotatic factor. Thus, monokine/endothelial cell interactions cannot only induced the adherence of neutrophils in a defined area of inflammation, but also initiate the unidirectional movement of these cells into an inflamed area in a polarized fashion. Interestingly, the induction of cytokine-induced NCF production by endothelial cells demonstrated selectivity, as IL-6 was not effective in this system. In total, these studies show that monokines can stimulate the production of a neutrophil chemotactic factor from human endothelial ceils that may have important consequences in acute, neutrophilmediated inflammation.
